Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

PlanDefinition: PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.17

Official URL: https://fevir.net/resources/PlanDefinition/179554 Version: 2.0.0-ballot
Active as of 2024-11-21 Computable Name:
Other Identifiers: FEvIR Object Identifier: 179554, OID:2.16.840.1.113883.4.642.40.44.34.2

Usage:Evidence Communication: RecommendationPlan

Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/

8.17 Metabolic surgery may be considered as an option to treat type 2 diabetes in adults with BMI 30.0–34.9 kg/m2 (27.5–32.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A

Generated Narrative: PlanDefinition 179554

version: 2; Last updated: 2023-11-24 22:42:27+0000

Profile: RecommendationPlan

url: PlanDefinition PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.17

identifier: FEvIR Object Identifier/179554, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.34.2

version: 2.0.0-ballot

title: PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.17

type: ECA Rule

status: Active

subject: RecommendationEligibilityCriteria: Bariatric Surgery Eligibility Group (ADA Recommendation 8.17)

date: 2024-11-21 14:09:14+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

8.17 Metabolic surgery may be considered as an option to treat type 2 diabetes in adults with BMI 30.0–34.9 kg/m2 (27.5–32.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationRecommendationPlan

jurisdiction: World

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

author: Brian S. Alper:

RelatedArtifacts

-TypeCitation
*Cite As

PlanDefinition for Recommendation: ADA Obesity Management Recommendation 8.17 [PlanDefinition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179554. Revised 2023-11-24. Available at: https://fevir.net/resources/PlanDefinition/179554. Computable resource at: https://fevir.net/resources/PlanDefinition/179554.

Actions

-TextEquivalent
*

Metabolic surgery may be considered.